Retour sur lavenir.net
   FAGRON 22.450 € (-0,66 %)     AB INBEV 73.020 € (-0,63 %)     KBC 126.900 € (+0,63 %)     KBC ANCORA 90.000 € (+0,67 %)     COLRUYT 38.960 € (-0,97 %)     UMICORE 22.060 € (+2,89 %)     AGEAS 74.900 € (+1,90 %)     ECONOCOM GROUP 1.530 € (-0,97 %)     ACKERMANS V.HAAREN 273.000 € (+1,04 %)     CMB.TECH 14.280 € (+1,56 %)     UCB 226.400 € (+2,26 %)     WDP 22.120 € (+0,09 %)     SYENSQO 78.700 € (+0,51 %)     TUBIZE-FIN 195.600 € (+1,66 %)     CARE PROPERTY INV. 12.540 € (-0,48 %)     ARGENX SE 726.400 € (+0,58 %)     ONTEX GROUP 2.330 € (+1,08 %)     ONWARD MEDICAL 2.350 € (+0,64 %)     GBL 79.000 € (0,00 %)     MELEXIS 70.200 € (+1,89 %)     BEKAERT 39.650 € (+1,54 %)     RECTICEL 12.320 € (-0,65 %)     LOTUS BAKERIES 11 220.000 € (+0,54 %)     SOLVAY 26.720 € (+0,53 %)     DEME GROUP 166.400 € (+0,60 %)     SOFINA 248.100 € (-0,04 %)     D'IETEREN GROUP 180.500 € (+0,28 %)     IBA 16.000 € (+0,38 %)     ELIA GROUP 126.100 € (+0,48 %)     BARCO 7.955 € (+0,82 %)     CENERGY 22.560 € (+2,17 %)     CAMPINE 207.000 € (0,00 %)     VAN DE VELDE 30.000 € (0,00 %)     VIOHALCO 18.300 € (0,00 %)     DECEUNINCK 2.175 € (+0,69 %)     QRF 10.400 € (0,00 %)     OXURION 0.003 € (+16,67 %)     SHURGARD 25.500 € (0,00 %)     CIE BOIS SAUVAGE 303.000 € (-0,33 %)     WAREHOUSES ESTATES 39.800 € (0,00 %)     KINEPOLIS GROUP 41.550 € (+0,12 %)     JENSEN-GROUP 86.200 € (0,00 %)     BPOST 1.536 € (+0,39 %)     HOME INVEST BE. 20.050 € (-0,50 %)     BIOTALYS 2.595 € (+1,37 %)     INCLUSIO SA/NV 16.800 € (0,00 %)     VGP 85.800 € (+0,23 %)     FLUXYS BELGIUM D 20.100 € (0,00 %)     AGFA-GEVAERT 0.383 € (-1,79 %)     EKOPAK 3.985 € (+2,18 %)     TEXAF 41.800 € (+0,97 %)     RETAIL ESTATES 66.300 € (-0,30 %)     NEXTENSA 44.605 € (+0,01 %)     BANIMMO A 2.980 € (+0,68 %)     BANQUP GROUP 2.030 € (-0,98 %)     SOLVAC NOM(RETAIL) 80.000 € (+0,63 %)     TESSENDERLO 21.650 € (+0,46 %)     OPTION 3.960 € (+1,54 %)     EXMAR 11.400 € (-0,87 %)     ACCENTIS 0.027 € (0,00 %)  
   EXOSENS 61.500 € (+3,71 %)     CVC CAPITAL 15.100 € (+0,53 %)     LIGHTON 4.045 € (+2,02 %)     FDJ UNITED 22.160 € (-1,03 %)     PLANISWARE 23.350 € (-1,27 %)     EMEIS 13.970 € (+0,07 %)     VIRIDIEN 86.550 € (-2,64 %)     CRCAM NORD CCI 29.600 € (+0,61 %)     ATON 0.011 € (0,00 %)     SODEXO 56.650 € (-0,87 %)     STMICROELECTRONICS 46.310 € (+2,30 %)     WORLDLINE 13.524 € (+0,46 %)     TOTALENERGIES 76.430 € (0,00 %)     BNP PARIBAS ACT.A 112.140 € (+0,32 %)     ALTEN 78.600 € (-0,38 %)     VALERIO TX 0.731 € (-1,75 %)     ICADE 19.540 € (-0,31 %)     ARKEMA 61.550 € (+0,65 %)     SCHNEIDER ELECTRIC 297.550 € (+2,57 %)     ADYEN 921.000 € (+1,41 %)     KERING 283.850 € (-1,58 %)     74SOFTWARE 38.000 € (+0,26 %)     DASSAULT AVIATION 309.400 € (+1,51 %)     ENGIE 27.240 € (+1,38 %)     TITAN 2.560 € (+9,40 %)     AIRBUS 212.200 € (+2,02 %)     LVMH 484.400 € (-0,51 %)     KPN KON 4.085 € (-0,32 %)     PHARMING GROUP 0.880 € (-0,34 %)     VOLTALIA 6.970 € (+0,29 %)     PROSUS 40.905 € (-0,01 %)     CAPGEMINI 106.400 € (-0,75 %)     EURONEXT 158.000 € (+0,57 %)     SAFRAN 357.600 € (+1,79 %)     DASSAULT SYSTEMES 20.700 € (-0,24 %)     TECHNIP ENERGIES 29.880 € (+0,61 %)     HERMES INTL 1 557.500 € (-0,19 %)     SOITEC 116.250 € (+6,36 %)     ORANGE 16.560 € (-0,27 %)     SHELL PLC 39.945 € (+0,35 %)     HAFFNER ENERGY 0.416 € (-5,67 %)     RELX 31.120 € (+0,19 %)     AIR LIQUIDE 171.300 € (+0,58 %)     UMG 14.460 € (+0,80 %)     WOLTERS KLUWER 69.540 € (-0,11 %)     LEGRAND 136.050 € (+1,15 %)     BE SEMICONDUCTOR 209.400 € (+3,97 %)     RENAULT 28.150 € (-1,05 %)     DANONE 67.580 € (-0,32 %)     ASM INTERNATIONAL 813.800 € (+2,34 %)     DSM FIRMENICH AG 92.740 € (+0,11 %)     ASML HOLDING 1 454.600 € (+2,47 %)     2CRSI 24.960 € (+1,71 %)     J.MARTINS,SGPS 17.620 € (0,00 %)     PUBLICIS GROUPE SA 93.100 € (-0,81 %)     NEDAP 96.300 € (+1,58 %)     RANDSTAD NV 37.490 € (-0,32 %)     EDP 4.476 € (+0,13 %)     FERMENTALG 0.461 € (0,00 %)     EDENRED 28.020 € (-1,13 %)  
GIMV
GIMB - BE0003699130 - Euronext Bruxelles
45,100 €  09:00
-0,11 %
30/06/2026 07:30

Gimv sells its stake in AlpenBlu Clinics (formerly Les Psy Réunis), a Swiss provider of outpatient mental healthcare, to Impact Healthcare.

Press release

Gimv NV - Karel Oomsstraat 37, 2018 Antwerp, Belgium - T +32 3 290 21 00 - www.gimv.com 1

Gimv sells its stake in AlpenBlu Clinics (formerly Les Psy Réunis), a Swiss provider of outpatient mental healthcare, to Impact Healthcare.

Gimv announces the sale of its majority stake in the leading Swiss outpatient mental healthcare platform AlpenBlu Clinics (former Les Psy Réunis) to Impact Healthcare (IHC), the healthcare investment platform of Swiss family-owned investment group Après-Demain, alongside the company's founders, who will lead its next phase of growth.

Founded by Drs. Elizabeth and Andrei Cicotti under the name Les Psy Réunis, AlpenBlu Clinics has grown into one of the leading outpatient mental healthcare providers in French-speaking Switzerland. The group operates a network of specialized psychiatric and psychological care centers across the cantons of Geneva, Vaud and Fribourg. Against a backdrop of rising demand for mental healthcare services, AlpenBlu Clincs has built a scalable operating platform that combines high-quality patient care with an attractive and collaborative environment for practitioners.

Since partnering with the founders in 2021, Gimv has supported the group in executing its growth strategy. It expanded its footprint across French-speaking Switzerland, both organically and inorganically, strengthened its management team and governance structures, invested in the digitalization of its operations and successfully adapted to an evolving regulatory environment, further reinforcing its position as a leading outpatient mental healthcare platform in the region.

The transaction marks the beginning of a new chapter for AlpenBlu Clinics. Together with the founders, Impact Healthcare will provide long-term support to accelerate the expansion of the network and continue investing in clinical excellence, talent and infrastructure.

Gautier Lefebvre, Kevin Klein and Hadrien Pigot, Gimv Healthcare, declare: “Since our investment, AlpenBlu Clinics has evolved into a more diversified, professionally managed and scalable platform. Together with the founders and the management, we have contributed to triple its size, build a strong foundation for future growth while helping the company navigate an evolving regulatory environment. We are proud of what has been achieved through this partnership based on trust and long-term vision. We are convinced that IHC has the ideal profile to continue this venture, and we wish the team every success in this next chapter.”

Drs. Elizabeth and Andrei Cicotti, Co-founders of AlpenBlu Clinics, jointly declare: “Gimv has been an instrumental partner in helping us professionalize and expand the organization while remaining true to our mission of delivering high-quality mental healthcare in a welcoming atmosphere. We look forward to continuing our development together with Impact Healthcare.”

Thierry Mauvernay, Alexandra Le Coz Sanchez and William Deflon of Impact Healthcare, declare: “We are pleased to take over from Gimv, who has successfully structured the company for the next phases of development, and we are excited to join forces with Drs. Elizabeth and Andrei Cicotti to continue providing high-quality patient care and offer them an integrated care pathway.”

The transaction reflects Gimv's ability to support entrepreneurial healthcare businesses in their transformation into market-leading platforms. This results in a return in line with Gimv’s long-term return target. Upon completion, the transaction will have a positive impact on Gimv's most recently communicated net asset value per share of approximately EUR 0.25.

Antwerp (BE), Paris (FR) & Lausanne (CH), June 30, 2026, 07:30 CET

Press release

Gimv NV - Karel Oomsstraat 37, 2018 Antwerp, Belgium - T +32 3 290 21 00 - www.gimv.com 2

About Gimv

Gimv is a European investment company listed on Euronext Brussels and a member of the Euronext BEL ESG Index. With over 45 years of private equity experience, Gimv currently manages more than EUR 2 billion of assets across a portfolio of some 60 companies, representing combined turnover of EUR 5 billion and more than 20,000 employees.

As a recognised market leader in four sector-focused investment platforms (Consumer, Healthcare, Smart Industries and Sustainable Cities) as well as through Gimv Anchor Investments, Gimv partners with entrepreneurial, innovative businesses with strong growth potential and supports their transformation into market leaders. Each platform operates with an experienced local team across Gimv’s home markets (Benelux, France and DACH), backed by an international network of experts.

Further information on Gimv can be found on www.gimv.com.

For further information please contact:

Kristof Vande Capelle, CFO*
T +32 3 290 22 17
kristof.vandecapelle@gimv.com

* acting on behalf of a company

About Impact Healthcare SA

Impact Healthcare’s mission is to positively influence people’s life journeys by building a coordinated ecosystem of services and innovations designed to better anticipate and address vulnerabilities, enabling more people to achieve their aspiration of living well and ageing well at home.

The company is owned by Après-Demain SA, a Swiss family-owned group comprising a life sciences platform (Debiopharm), a diversified investment platform (www.apres-demain.com), and a philanthropic foundation (www.fondationnext.com).

Our entrepreneurial culture and our ability to partner with management teams over the long term are at the heart of our investment philosophy and daily commitment.

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière